Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis - PubMed (original) (raw)
Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis
I Herr et al. EMBO J. 1997.
Abstract
We report here that anticancer drugs such as doxorubicin lead to induction of the CD95 (APO-1/Fas) system of apoptosis and the cellular stress pathway which includes JNK/SAPKs. Ceramide, which accumulates in response to different types of cellular stress such as chemo- and radiotherapy, strongly induced expression of CD95-L, cleavage of caspases and apoptosis. Antisense CD95-L as well as dominant-negative FADD inhibited ceramide- and cellular stress-induced apoptosis. Fibroblasts from type A Niemann-Pick patients (NPA), genetically deficient in ceramide synthesis, failed to up-regulate CD95-L expression and to undergo apoptosis after gamma-irradiation or doxorubicin treatment. In contrast, JNK/SAPK activity was still inducible by doxorubicin in the NPA cells, suggesting that activation of JNK/SAPKs alone is not sufficient for induction of the CD95 system and apoptosis. CD95-L expression and apoptosis in NPA fibroblasts were restorable by exogenously added ceramide. In addition, NPA fibroblasts undergo apoptosis after triggering of CD95 with an agonistic antibody. These data demonstrate that ceramide links cellular stress responses induced by gamma-irradiation or anticancer drugs to the CD95 pathway of apoptosis.
Similar articles
- JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL and TNF-alpha.
Herr I, Wilhelm D, Böhler T, Angel P, Debatin KM. Herr I, et al. Int J Cancer. 1999 Jan 29;80(3):417-24. doi: 10.1002/(sici)1097-0215(19990129)80:3<417::aid-ijc14>3.0.co;2-b. Int J Cancer. 1999. PMID: 9935184 - Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases.
Brenner B, Ferlinz K, Grassmé H, Weller M, Koppenhoefer U, Dichgans J, Sandhoff K, Lang F, Gulbins E. Brenner B, et al. Cell Death Differ. 1998 Jan;5(1):29-37. doi: 10.1038/sj.cdd.4400307. Cell Death Differ. 1998. PMID: 10200443 - Molecular mechanisms of ceramide-mediated CD95 clustering.
Grassmé H, Schwarz H, Gulbins E. Grassmé H, et al. Biochem Biophys Res Commun. 2001 Jun 22;284(4):1016-30. doi: 10.1006/bbrc.2001.5045. Biochem Biophys Res Commun. 2001. PMID: 11409897 - [Ceramide: a lipid mediator of apoptotic signal transduction].
Sawai H, Okazaki T, Domae N. Sawai H, et al. Nihon Rinsho. 1996 Jul;54(7):1803-8. Nihon Rinsho. 1996. PMID: 8741670 Review. Japanese. - Stress signals for apoptosis: ceramide and c-Jun kinase.
Basu S, Kolesnick R. Basu S, et al. Oncogene. 1998 Dec 24;17(25):3277-85. doi: 10.1038/sj.onc.1202570. Oncogene. 1998. PMID: 9916990 Review.
Cited by
- Advancements on the Multifaceted Roles of Sphingolipids in Hematological Malignancies.
Raza Y, Atallah J, Luberto C. Raza Y, et al. Int J Mol Sci. 2022 Oct 22;23(21):12745. doi: 10.3390/ijms232112745. Int J Mol Sci. 2022. PMID: 36361536 Free PMC article. Review. - Dihydroceramide desaturase 1 (DES1) promotes anchorage-independent survival downstream of HER2-driven glucose uptake and metabolism.
Linzer RW, Guida DL, Aminov J, Snider JM, Khalife G, Buyukbayraktar AB, Alhaddad C, Resnick AE, Wang P, Pan CH, Allopenna JJ, Clarke CJ. Linzer RW, et al. FASEB J. 2022 Oct;36(10):e22558. doi: 10.1096/fj.202200748R. FASEB J. 2022. PMID: 36165222 Free PMC article. - The regulatory function of mixed lineage kinase 3 in tumor and host immunity.
Kumar S, Singh SK, Rana B, Rana A. Kumar S, et al. Pharmacol Ther. 2021 Mar;219:107704. doi: 10.1016/j.pharmthera.2020.107704. Epub 2020 Oct 9. Pharmacol Ther. 2021. PMID: 33045253 Free PMC article. Review. - Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies.
Lewis AC, Wallington-Beddoe CT, Powell JA, Pitson SM. Lewis AC, et al. Cell Death Discov. 2018 Jun 28;4:72. doi: 10.1038/s41420-018-0075-0. eCollection 2018. Cell Death Discov. 2018. PMID: 30062053 Free PMC article. - Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia.
Wątek M, Durnaś B, Wollny T, Pasiarski M, Góźdź S, Marzec M, Chabowska A, Wolak P, Żendzian-Piotrowska M, Bucki R. Wątek M, et al. Lipids Health Dis. 2017 Dec 8;16(1):235. doi: 10.1186/s12944-017-0624-1. Lipids Health Dis. 2017. PMID: 29216917 Free PMC article.
References
- Cell. 1995 Aug 11;82(3):405-14 - PubMed
- J Immunol. 1988 Oct 15;141(8):2629-34 - PubMed
- Nature. 1996 Mar 7;380(6569):75-9 - PubMed
- J Biol Chem. 1994 Feb 25;269(8):5757-63 - PubMed
- Immunol Rev. 1994 Dec;142:175-91 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous